INFANT BACTERIAL THERAPEUTICS AB

Insiders Infant Bacterial Therapeutics AB

Equities

IBT B

SE0008015259

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
98.6 ^SEK	-2.38%		+2.71%	+9.56%

Jul. 08	Infant Bacterial Therapeutics AB Completes Clinical Development Program	CI
May. 07	Infant Bacterial Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Infant Bacterial Therapeutics AB Announces the Appointment of the Nomination Committee for the Annual General Meeting 2024	23-10-24	CI
Infant Bacterial Therapeutics AB Announces Nomination Committee Appointments	22-11-04	CI
Infant Bacterial Therapeutics AB Announces Management Changes	22-05-04	CI
Infant Bacterial Therapeutics AB Announces Composition of Nomination Committee	21-11-01	CI
Infant Bacterial Therapeutics AB Elects Robert Molander as Board Member	20-06-16	CI
Infant Bacterial Therapeutics AB Announces Resignation of Lilian Wikström from the Board of Directors	19-11-05	CI
Infant Bacterial Therapeutics AB Appoints Members to its Nomination Committee	18-10-09	CI
Infant Bacterial Therapeutics AB Announces Board Appointments	18-05-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer